A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

• প্রধান লেখক: Kai Huang (লেখক), Linling Que (লেখক), Ying Ding (লেখক), Nannan Chu (লেখক), Zhenzhong Qian (লেখক), Yunfei Shi (লেখক), Wei Qin (লেখক), Zhenni Li (লেখক), Yuanxin Chen (লেখক), Xianghong Gu (লেখক), Jiakun Wang (লেখক), Lin Zhang (লেখক), Jisheng Zhang (লেখক), Xiangyang Zhu (লেখক), Yongmin Yang (লেখক), Yuan Tang (লেখক), Qing He (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Objective: This study was conducted to compare the pharmacokinetics, safety and immunogenicity of HOT-1010 with bevacizumab (Avastin®) in Chinese healthy male subjects.Methods: A single-center, randomized, double-blind, single-dose, parallel trial was performed in 84 Chinese healthy male subjects wh...